Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION(R) Platform at the European Society of Medical Oncology Annual Congress

(LSE – AIM:AVCT), Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the benchmark PFS and a disease control rate of 91% No maximum tolerated dose reached despite dosing up to 385 mg/m(2) (approximately 4x conventional […]

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION(R) Platform at the European Society of Medical Oncology Annual Congress

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION(R) Platform at the European Society of Medical Oncology Annual Congress GlobeNewswire October 19, 2025 Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the

Lost Money on WPP plc (WPP)? Contact Levi & Korsinsky to Join Class Action Before December 8, 2025

NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / NEW YORK, NY / ACCESS Newswire / October 19, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=172844&wire=1&utm_campaign=20

Max Stock Limited releases an immediate report on holdings of interested parties and senior officers as of September 30, 2025

Regulations 33(c)-(d) of the Securities Regulations (Periodic and Immediate Reports), 1970 Max Stock Limited (TASE: MAXO) (the “Company”) today announced holdings of interested parties and senior officers as of September 30, 2025: A. Corporation's interested parties (including the CEO and directors, and including any other employee holding 5% or more of the corporation's issued share

HDAI to announce AI tools that drive quality outcomes at HLTH 2025

Nassib Chamoun, CEO of Health Data Analytics Institute (HDAI), a leader in enterprise risk stratification, will be speaking about “Crystal Ball Medicine” at HLTH in Las Vegas this week. At the event, Chamoun, an experienced health tech entrepreneur, will announce the general availability of the first real-time, EHR-embedded, full-record AI chart summaries, extending HDAI's AI

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Vera Bradley, Inc. Investors to Inquire About Securities Class Action Investigation – VRA

NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / WHY: New York, N.Y., October 19, 2025. Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ:VRA) resulting from allegations that Vera Bradley may have issued materially misleading business

PayrollOrg’s Educational Institutions Payroll Conference to Equip Higher Ed Payroll Professionals with Essential Compliance and Technology Insights

PayrollOrg will deliver critical updates on compliance and operational issues impacting payroll professionals at colleges and universities at its 38th Annual Educational Institutions Payroll Conference (EIPC), October 19 through 22, in San Antonio, Texas. https://mma.prnewswire.com/media/2068014/PayrollOrg_Logo.jpg “EIPC is an essential forum for payroll professionals in higher education to remain current on the regulatory changes and operational

ROSEN, A LEADING GLOBAL LAW FIRM, Encourages Sina Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SINA

(NASDAQ:SINA), NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) between October 13, 2020 and March 22, 2021, both dates inclusive (the “Class Period”), of the important November 18,

ROSEN, A LEADING GLOBAL LAW FIRM, Encourages Sina Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SINA

ROSEN, A LEADING GLOBAL LAW FIRM, Encourages Sina Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SINA GlobeNewswire October 19, 2025 NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the

SystImmune Announces iza-bren Meets One of the Dual Primary Endpoints in the BL-B01D1-303 Trial in Recurrent or Metastatic NPC Patients with Results Presented as a Late-Breaking Oral Presentation at ESMO

Results from the BL-B01D1-303 (NCT06118333) phase III trial presented in a late-breaking oral presentation at ESMO represents the first data readout for iza-bren from a registration enabling study in China SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the BL-B01D1-301 trial. The trial has met one of the dual primary

Scroll to Top